Details of the Drug
General Information of Drug (ID: DM4IA92)
Drug Name |
N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-(3-phenyl-1,2,4-thiadiazol-5-yl)benzamide; CHEMBL165783; AC1M3OE0; N-(3-Phenyl-[1,2,4]thiadiazol-5-yl)-benzamide; MolPort-000-646-915; HMS3451M02; ZINC2889428; STL202734; BDBM50097440; AKOS000813205; MCULE-2440953367; UPCMLD0ENAT5889812:001; ST45223360; VU0618368-1; N-(3-Phenyl-1,2,4-thiadiazole-5-yl)benzamide; phenyl-N-(3-phenyl(1,2,4-thiadiazol-5-yl))carboxamide; F3394-1092
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 281.3 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 3.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 4 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||